REZLIDHIA Net Product Sales for Q4 2024: $7.4 million, a 92% increase year over year ... Expected Net Product Sales for 2025: ...

Analysts at HC Wainwright issued their Q3 2025 EPS estimates for Rigel Pharmaceuticals in a research report issued to clients ...

Equities research analysts at Cantor Fitzgerald increased their FY2025 earnings per share estimates for Rigel Pharmaceuticals ...

Before you invest in Rigel Pharmaceuticals, Inc. (RIGL), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

B. Riley raised the firm’s price target on Rigel Pharmaceuticals (RIGL) to $24 from $20 and keeps a Neutral rating on the shares following the Q4 report. The upside was driven primarily by ...